期刊文献+

96株肺炎链球菌耐药性分析 被引量:7

Analysis on 96 Infected Cases of Streptococcus Pneumoniae
下载PDF
导出
摘要 目的了解肺炎链球菌常见的感染类型、对药物的敏感性,为临床正确诊治提供循证依据。方法回顾分析本院2010年1月~2011年12月临床确诊为肺炎链球菌感染的病例,采用纸片扩散法检测左氧氟沙星、万古霉素、复方磺胺、红霉素、克林霉素的敏感性,E-test方法测试分离菌对青霉素的最低抑菌浓度(MIC),用Whonet5.5软件分析青霉素MIC的分布及MIC50和MIC90。结果共分离出肺炎链球菌96株,标本来源应以下呼吸道感染为主(81例84.4%),肺炎链球菌青霉素的MIC分布范围为(0.016~64)μg/ml,呼吸系统和血流感染静脉用青霉素的敏感率为97.5%(79/81)。结论肺炎链球菌感染以呼吸系统感染为主,感染人群以儿童为主,成人感染多并发肿瘤、COPD、风湿等基础疾病。呼吸、感染的肺炎链球菌对静脉用青霉素、万古霉素和左氧氟沙星保持较高的敏感性。影响治疗成败的关键因素是感染部位和治疗的及时性。 Objective To investigate the varieties of infections, susceptibilities of S. pneumoniae isolated from in- fected patients ,to find the leading causes of illness and treatment failures. Methods A retrospective analysis was made to the S. pneumoniae injected cases of our hospital from January 2010 to December 2011. The minimum inhibitory concentra- tions (MICs) of penicillin and zone diameter of other antimicrobial agents were determined by Etest and disk diffusion method respectively. WHONET5.5 software was used to analyze penicillin MICs distribution,MIC50 and MIC90. Results A total of 96 patients were infected by S. pneumoniae, of which respiratory system infections, bloodstream infections, centre nervous system infections,bloodstream and centre nervous system infections, intra-abdominal infections, thorax in- fection,septic thyroisitis and otitis media were the leading illness, accounting for 84.4%, 6.3%, 2.1% ,3.1%,1.0%, 1.0%, 1.0% and 1.0% respectively. Those patients included children and adults, accounting for 72.9%, 27. 1% respec- tively. Penicillin MICs distribution ranged from 0. 016 to 64 ug/ml, MICS0 2 /μg/ml,MIC90 2 μg/ml. Penicillin,van- comycin and leve-flocacin showed excellent activities against S. pneumoniae isolated from bloodstream and sputum, The ac-tivities of erythromycin, clindamycin, trimethoprln/suttameuJux~'"~ o^s ~ main varieties infections of S. pneumoniae were respiratory tract,bloodstream and centre nervous system infections. Chil- dren and adults who had underlying medical conditions such as active malignancies, COPD and rheumatism were the domi- nant persons suffered it. The main reason for failure to respond was progression of pathophysiological changes despite ap- propriate antibiotic treatment.
出处 《临床输血与检验》 CAS 2012年第4期319-321,共3页 Journal of Clinical Transfusion and Laboratory Medicine
关键词 肺炎链球菌 感染 耐药 Streptococcus pneumoniae Infection Resistance
  • 相关文献

参考文献4

  • 1Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of commurfity-acquired pneumonia in adults[J]. Clinical infectious diseases, 2000,31(2) :347-382. 被引量:1
  • 2Rotstein C,Evans G, Born A, et al, Clincical practice guidelines for hospital-acquired pneumonia and venti- lator-associated pneumonia in adult[J]. Can J Infect Dis Med Microbiol, 2008,19 (1) : 19-53. 被引量:1
  • 3Clinical and Laboratory Standards Institute (CLSI) . Performance standards for Antimicrobial susceptibility testing [S]. M100-S20, 2010. 被引量:1
  • 4杨启文,王瑶,陈民钧,孙宏莉,胡云建,倪语星,俞云松,吴伟元,叶惠芬,季萍,任健康,孙自镛,童明庆,赵旺胜,刘勇,段琼,刘蓬蓬,王晶,王辉,谢秀丽,徐英春.中国14家教学医院2005-2008年临床分离肺炎链球菌耐药性分析[J].中华检验医学杂志,2011,34(6):511-516. 被引量:23

二级参考文献10

  • 1Liu Y,Chen M,Zhao T,et al.Causative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban population.BMC Infect Dis,2009,18:31. 被引量:1
  • 2Jones RN,Jacobs MR,Sader HS.Evolving trends in Streptococcus pneumoniae resistance:implications for therapy of community-acquired bacterial pneumonia.Int J Antimicrob Agents,2010,36:197-204. 被引量:1
  • 3Lynch JP 3rd,Zhanel GG.Streptococcus pneumoniae:does antimicrobial resistance matter? Semin Respir Crit Care Med,2009,30:210-238. 被引量:1
  • 4Clinical and Laboratory Standards Institute.CLSI documents M7-A8 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-seventh Edition; Approved Standard.Wayne,Pa:CLSI,2009,29. 被引量:1
  • 5Clinical and Laboratory Standards Institute.CLSI documents M2-A10 Performance standards for antimicrobial Disk susceptibility tests; Approved Standard-tenth edition.Wayne,Pa:CLSI,2009,29. 被引量:1
  • 6Clinical and Laboratory Standards Institute.CLSI documents M100-S20 Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement.Wayne,Pa:CLSI,2010,30. 被引量:1
  • 7Do(g)an O,Gülmez D,Has(c)elik G.Effect of New Breakpoints Proposed by Clinical and Laboratory Standards Institute in 2008 for Evaluating Penicillin Resistance of Streptococcus pneumoniae in a Turkish University Hospital.Microb Drug Resist,2010,16:39-41. 被引量:1
  • 8Hoenigl M,Fussi P,Feierl G,et al.Antimicrobial resistance of Streptococcus pneumoniae in Southeast Austria,1997-2008.Int J Antimicrob Agents,2010,36:24-27. 被引量:1
  • 9Pérez-Trallero E,Martín-Herrero JE,Mazón A,et al.Antimicrobial Resistance among Respiratory Pathogens in Spain:Latest Data and Changes over 11 Years (1996-1997 to 2006-2007).Antimicrob Agents Chemother,2010,54:2953-2959. 被引量:1
  • 10Marie Kempf,Regine Baraduc,Henri Bonnabau,et al.Epidemiology and Antimicrobial Resistance of Streptococcus pneumoniae in France in 2007:Data from the Pneumococcus Surveillance Network[J/OL].Microb Drug Resist,2010,[2010-10-14].http://www.ncbi.nlm.nih.gov/pubmed/20809835.[published online ahead of print Sep 1,2010]. 被引量:1

共引文献22

同被引文献58

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部